Leading the way to safer medication

Atomoxetine

(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine

STRATTERA

Therapeutic Indications

Atomoxetine is indicated for:

Hyperkinetic disorders

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Treatment 2: Oral

Hyperkinetic disorders

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Contraindications

Active ingredient Atomoxetine is contraindicated in the following cases:

No gender/age discrimination

at least one of
MAO inhibitors
Primary angle-closure glaucoma
Pheochromocytoma

No gender/age discrimination

at least one of
Pregnancy
Lactation

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines

MPI, EU: SmPC 2015: SPC, UK: STRATTERA Hard capsules
MPI, EU: SmPC 2012: SPC, UK: Strattera 10mg, 18mg, 25mg, 40mg, 60mg, 80mg or 100mg hard capsules

< Previous: Overview
Next: Precautions >